Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
OptimizeRx Corporation - Common Stock
(NQ:
OPRX
)
6.175
-0.285 (-4.41%)
Streaming Delayed Price
Updated: 11:08 AM EDT, Jul 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
95,669
Open
6.400
Bid (Size)
6.160 (300)
Ask (Size)
6.190 (400)
Prev. Close
6.460
Today's Range
6.175 - 6.400
52wk Range
4.540 - 22.25
Shares Outstanding
17,618,607
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
Today 7:30 EDT
Leading pharmaceutical marketing executive joins leadership team to accelerate innovation and strengthen partnerships across the life sciences industry
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
June 30, 2026
Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP intent is highest
From
OptimizeRx Corporation
Via
GlobeNewswire
Performance
YTD
-50.3%
-50.3%
1 Month
+31.9%
+31.9%
3 Month
-9.2%
-9.2%
6 Month
-47.0%
-47.0%
1 Year
-53.6%
-53.6%
More News
Read More
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
June 25, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance
↗
May 12, 2026
Via
Chartmill
OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook
↗
March 05, 2026
Via
Chartmill
MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
June 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
OptimizeRx to Participate in Upcoming Investor Conferences
June 01, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
May 21, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx (OPRX) Q1 2026 Earnings Transcript
↗
May 14, 2026
Via
The Motley Fool
OptimizeRx Q1 Earnings Call Highlights
↗
May 12, 2026
Via
MarketBeat
Topics
Earnings
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
May 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
May 11, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
April 29, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
April 28, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Discover the top movers in Wednesday's pre-market session.
↗
March 18, 2026
Via
Chartmill
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript
↗
March 05, 2026
Via
The Motley Fool
Topics
Earnings
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Whetstone Capital Exits GitLab as Enterprises Rethink AI-Driven Software Development Tools
↗
February 26, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million
↗
February 21, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
February 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
January 07, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
December 17, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year
↗
December 08, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors
↗
December 08, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Frequently Asked Questions
Is OptimizeRx Corporation - Common Stock publicly traded?
Yes, OptimizeRx Corporation - Common Stock is publicly traded.
What exchange does OptimizeRx Corporation - Common Stock trade on?
OptimizeRx Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OptimizeRx Corporation - Common Stock?
The ticker symbol for OptimizeRx Corporation - Common Stock is OPRX on the Nasdaq Stock Market
What is the current price of OptimizeRx Corporation - Common Stock?
The current price of OptimizeRx Corporation - Common Stock is 6.175
When was OptimizeRx Corporation - Common Stock last traded?
The last trade of OptimizeRx Corporation - Common Stock was at 07/23/26 11:08 AM ET
What is the market capitalization of OptimizeRx Corporation - Common Stock?
The market capitalization of OptimizeRx Corporation - Common Stock is 108.79M
How many shares of OptimizeRx Corporation - Common Stock are outstanding?
OptimizeRx Corporation - Common Stock has 109M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.